Early stage cancer in older adults: Prostate-avoiding overtreatment and undertreatment

Cancer Journal (United States)

Volumn 23, Issue 4, 2017, Pages 238-241

  Narayan, Vikram ^a   Jiang, Song ^a   Warlick, Christopher A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Elderly men; geriatric assessment tools; life expectancy; prostate cancer

Indexed keywords

AGED; CANCER THERAPY; EARLY CANCER; GERIATRIC ASSESSMENT; GERIATRIC PATIENT; HUMAN; LIFE EXPECTANCY; PATIENT COUNSELING; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; REVIEW; AGE; CANCER STAGING; HEALTH SERVICE; MALE; PATHOLOGY; PROSTATE TUMOR; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; GERIATRIC ASSESSMENT; HEALTH SERVICES MISUSE; HUMANS; LIFE EXPECTANCY; MALE; MEDICAL OVERUSE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 85026796220     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0000000000000273     Document Type: Review

References (29)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CACancer J Clin. 2016; 66: 7-30.
2. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2008 [Internet]. Available at: http://seer.cancer.gov/csr/1975-2005/. Accessed January 1, 2017.
3. Epstein MM, Edgren G, Rider JR, et al. Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst. 2012; 104: 1335-1342.
4. Andriole GL, Crawford ED, Grubb RL, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360: 1310-1319.
5. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360: 1320-1328.
6. Moyer VA. Screening for prostate cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012; 157: 120-134.
7. Carter B, Albertsen P, Barry M, et al. Early detection of prostate cancer: AUA guideline. J Urol. 2013; 190: 419-426.
8. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst. 2009; 101: 1325-1329.
9. Kramer BS. The science of early detection. Urol Oncol. 2004; 22: 344-347.
10. Albertsen PC, Hanley JA, Gleason DF, et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA. 1998; 280: 975-980.
11. Albertsen PC, Hanley JA, Fine J. 20-Year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005; 293: 2095-2101.
12. Bill-Axelson A, Holmberg L, Garmo H, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014; 370: 932-942.
13. Hamdy FC, Donovan JL, Lane JA, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016; 375: 1415-1424.
14. Xu J, Murphy S, Kochanek K, et al. Mortality in the United States, 2015. Natl Cent Heal Stat Data Br. 2016; 64: 1-117.
15. Sammon JD, Abdollah F, DAmico A, et al. Predicting life expectancy in men diagnosed with prostate cancer. Eur Urol. 2015; 68: 756-765.
16. Koch MO, Miller DA, Butler R, et al. Arewe selecting the right patients for treatment of localized prostate cancer? Results of an actuarial analysis. Urology. 1998; 51: 197-202.
17. Wilson JR, Clarke MG, Ewings P, et al. The assessment of patient lifeexpectancy: how accurate are urologists and oncologists? BJU Int. 2005; 95: 794-798.
18. Social Security Administration. Actuarial Life Tables [Internet]. Cited January 1, 2017. Available at: https://www.ssa.gov/oact/STATS/table4c6.html. Accessed January 1, 2017.
19. Life Expectancy Calculators [Internet]. Cited January 1, 2017. Available at: http://www.lifeexpectancycalculators.com/actuarial-lifetables.html. Accessed January 1, 2017.
20. Abaris: how long will I live? [Internet]. Cited January 1, 2017. Available at: https://www.myabaris.com/tools/life-expectancy-calculator-how-longwill-i-live/. Accessed January 1, 2017.
21. Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specificmortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388: 1459-1544.
22. Sweat SD, Bergstralh EJ, Slezak J, et al. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol. 2002; 168: 525-529.
23. Droz JP, Aapro M, Balducci L, et al. Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. Lancet Oncol. 2014; 15: e404-e414.
24. Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000; 36: 453-471.
25. Blanc-Bisson C, Fonck M, Rainfray M, et al. Undernutrition in elderly patients with cancer: target for diagnosis and intervention. Crit Rev Oncol Hematol. 2008; 67: 243-254.
26. Bharadwaj S, Ginoya S, Tandon P, et al. Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep (Oxf ). 2016; 4: 272-280.
27. Van Tol-Geerdink JJ, Stalmeier PF, van Lin EN, et al. Do patients with localized prostate cancer treatment really want more aggressive treatment? J Clin Oncol. 2006; 24: 4581-4586.
28. Thompson RH, Slezak JM, Webster WS, et al. Radical prostatectomy for octogenarians: how old is too old? Urology. 2006; 68: 1042-1045.
29. Stangelberger A, Waldert M, Djavan B. Prostate cancer in elderly men. Rev Urol. 2008; 10: 111-119.